Global Calcium Channel Blocker Market Insights, Research, Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 114

Report ID: 9086

Calcium channel blockers(CCBs) are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
The demand of Calcium Channel Blocker is concentrated in developed areas like USA and Europe. In 2016, the consumption of Calcium Channel Blocker in USA was 26.78%, ahead of other regions. Other regions also enjoy the major market share in global region.
In the future, the Calcium Channel Blocker will have a good future; the price fluctuation has relationship with the raw material. The technology will more mature and the monopoly phenomenon will be weaken. The installed rate in the commercial vehicle will increase.
The global Calcium Channel Blocker market is valued at 72 million US$ in 2018 and will reach 81 million US$ by the end of 2025, growing at a CAGR of 1.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Calcium Channel Blocker market based on company, product type, end user and key regions.

This report studies the global market size of Calcium Channel Blocker in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Calcium Channel Blocker in these regions.
This research report categorizes the global Calcium Channel Blocker market by top players/brands, region, type and end user. This report also studies the global Calcium Channel Blocker market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
AstraZeneca
Novartis
Sanofi

Market size by Product
Dihydropyridine
Diltiazem
Verapamil
Others
Market size by End User
Hypertension
Coronary Artery Disease
Arrhythmia
Cardiomyopathy

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Calcium Channel Blocker market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Calcium Channel Blocker market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Calcium Channel Blocker companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Calcium Channel Blocker submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Calcium Channel Blocker are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Calcium Channel Blocker market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Calcium Channel Blocker Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Calcium Channel Blocker Market Size Growth Rate by Product
1.4.2 Dihydropyridine
1.4.3 Diltiazem
1.4.4 Verapamil
1.4.5 Others
1.5 Market by End User
1.5.1 Global Calcium Channel Blocker Market Size Growth Rate by End User
1.5.2 Hypertension
1.5.3 Coronary Artery Disease
1.5.4 Arrhythmia
1.5.5 Cardiomyopathy
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Calcium Channel Blocker Market Size
2.1.1 Global Calcium Channel Blocker Revenue 2014-2025
2.1.2 Global Calcium Channel Blocker Sales 2014-2025
2.2 Calcium Channel Blocker Growth Rate by Regions
2.2.1 Global Calcium Channel Blocker Sales by Regions
2.2.2 Global Calcium Channel Blocker Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Calcium Channel Blocker Sales by Manufacturers
3.1.1 Calcium Channel Blocker Sales by Manufacturers
3.1.2 Calcium Channel Blocker Sales Market Share by Manufacturers
3.1.3 Global Calcium Channel Blocker Market Concentration Ratio (CR5 and HHI)
3.2 Calcium Channel Blocker Revenue by Manufacturers
3.2.1 Calcium Channel Blocker Revenue by Manufacturers (2014-2019)
3.2.2 Calcium Channel Blocker Revenue Share by Manufacturers (2014-2019)
3.3 Calcium Channel Blocker Price by Manufacturers
3.4 Calcium Channel Blocker Manufacturing Base Distribution, Product Types
3.4.1 Calcium Channel Blocker Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Calcium Channel Blocker Product Type
3.4.3 Date of International Manufacturers Enter into Calcium Channel Blocker Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Calcium Channel Blocker Sales by Product
4.2 Global Calcium Channel Blocker Revenue by Product
4.3 Calcium Channel Blocker Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Calcium Channel Blocker Breakdown Data by End User

6 North America
6.1 North America Calcium Channel Blocker by Countries
6.1.1 North America Calcium Channel Blocker Sales by Countries
6.1.2 North America Calcium Channel Blocker Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Calcium Channel Blocker by Product
6.3 North America Calcium Channel Blocker by End User

7 Europe
7.1 Europe Calcium Channel Blocker by Countries
7.1.1 Europe Calcium Channel Blocker Sales by Countries
7.1.2 Europe Calcium Channel Blocker Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Calcium Channel Blocker by Product
7.3 Europe Calcium Channel Blocker by End User

8 Asia Pacific
8.1 Asia Pacific Calcium Channel Blocker by Countries
8.1.1 Asia Pacific Calcium Channel Blocker Sales by Countries
8.1.2 Asia Pacific Calcium Channel Blocker Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Calcium Channel Blocker by Product
8.3 Asia Pacific Calcium Channel Blocker by End User

9 Central & South America
9.1 Central & South America Calcium Channel Blocker by Countries
9.1.1 Central & South America Calcium Channel Blocker Sales by Countries
9.1.2 Central & South America Calcium Channel Blocker Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Calcium Channel Blocker by Product
9.3 Central & South America Calcium Channel Blocker by End User

10 Middle East and Africa
10.1 Middle East and Africa Calcium Channel Blocker by Countries
10.1.1 Middle East and Africa Calcium Channel Blocker Sales by Countries
10.1.2 Middle East and Africa Calcium Channel Blocker Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Calcium Channel Blocker by Product
10.3 Middle East and Africa Calcium Channel Blocker by End User

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Calcium Channel Blocker Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer Calcium Channel Blocker Products Offered
11.1.5 Pfizer Recent Development
11.2 Aventis
11.2.1 Aventis Company Details
11.2.2 Company Business Overview
11.2.3 Aventis Calcium Channel Blocker Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Aventis Calcium Channel Blocker Products Offered
11.2.5 Aventis Recent Development
11.3 Searle
11.3.1 Searle Company Details
11.3.2 Company Business Overview
11.3.3 Searle Calcium Channel Blocker Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Searle Calcium Channel Blocker Products Offered
11.3.5 Searle Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Company Business Overview
11.4.3 Bayer Calcium Channel Blocker Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Bayer Calcium Channel Blocker Products Offered
11.4.5 Bayer Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 Company Business Overview
11.5.3 AstraZeneca Calcium Channel Blocker Sales, Revenue and Gross Margin (2014-2019)
11.5.4 AstraZeneca Calcium Channel Blocker Products Offered
11.5.5 AstraZeneca Recent Development
11.6 Knoll Pharmaceuticals
11.6.1 Knoll Pharmaceuticals Company Details
11.6.2 Company Business Overview
11.6.3 Knoll Pharmaceuticals Calcium Channel Blocker Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Knoll Pharmaceuticals Calcium Channel Blocker Products Offered
11.6.5 Knoll Pharmaceuticals Recent Development
11.7 Wyeth-Ayerst
11.7.1 Wyeth-Ayerst Company Details
11.7.2 Company Business Overview
11.7.3 Wyeth-Ayerst Calcium Channel Blocker Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Wyeth-Ayerst Calcium Channel Blocker Products Offered
11.7.5 Wyeth-Ayerst Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 Company Business Overview
11.8.3 AstraZeneca Calcium Channel Blocker Sales, Revenue and Gross Margin (2014-2019)
11.8.4 AstraZeneca Calcium Channel Blocker Products Offered
11.8.5 AstraZeneca Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Company Business Overview
11.9.3 Novartis Calcium Channel Blocker Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Novartis Calcium Channel Blocker Products Offered
11.9.5 Novartis Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Company Business Overview
11.10.3 Sanofi Calcium Channel Blocker Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Sanofi Calcium Channel Blocker Products Offered
11.10.5 Sanofi Recent Development

12 Future Forecast
12.1 Calcium Channel Blocker Market Forecast by Regions
12.1.1 Global Calcium Channel Blocker Sales Forecast by Regions 2019-2025
12.1.2 Global Calcium Channel Blocker Revenue Forecast by Regions 2019-2025
12.2 Calcium Channel Blocker Market Forecast by Product
12.2.1 Global Calcium Channel Blocker Sales Forecast by Product 2019-2025
12.2.2 Global Calcium Channel Blocker Revenue Forecast by Product 2019-2025
12.3 Calcium Channel Blocker Market Forecast by End User
12.4 North America Calcium Channel Blocker Forecast
12.5 Europe Calcium Channel Blocker Forecast
12.6 Asia Pacific Calcium Channel Blocker Forecast
12.7 Central & South America Calcium Channel Blocker Forecast
12.8 Middle East and Africa Calcium Channel Blocker Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Calcium Channel Blocker Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer